Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer
Jin-Zhong Sun,1,* Chuang Chen,1,* Guan Jiang,2 Wei-Qun Tian,3 Yan Li,4 Sheng-Rong Sun1 1Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China; 2Department of Dermatology, Renmin Hospital of Wuhan University, Wuhan, Hubei, Peo...
Enregistré dans:
Auteurs principaux: | Sun JZ, Chen C, Jiang G, Tian WQ, Li Y, Sun SR |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ff06d15109e54d54be2821c99b5badfc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The prognostic value of quantitative analysis of CCL5 and collagen IV in luminal B (HER2–) subtype breast cancer by quantum-dot-based molecular imaging
par: Zhu YY, et autres
Publié: (2018) -
Quantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer
par: Zheng H, et autres
Publié: (2016) -
Protein co-expression networks identified from HOT lesions of ER+HER2–Ki-67high luminal breast carcinomas
par: Kimito Yamada, et autres
Publié: (2021) -
Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients
par: Junmei Hao, et autres
Publié: (2021) -
Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
par: Ceren Boyaci, et autres
Publié: (2021)